Altug Tuncel

Altug Tuncel

Auto-generated profile, based on publicly available information

Altug Tuncel

Department of Urology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2006 in European Urology
Verified
Journal Article
Closed access
ATAltug Tuncel
Altug Tuncel
OAOmur Aydin
Omur Aydin
UTUmit Tekdogan
Umit Tekdogan
VNVarol Nalcacioglu
Varol Nalcacioglu
YCYusuf Capar
Yusuf Capar
AAAli Atan
Ali Atan

24 October 2009 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
ATAltug Tuncel
Altug Tuncel
VNVarol Nalcacioglu
Varol Nalcacioglu
KEKemal Ener
Kemal Ener
YAYilmaz Aslan
Yilmaz Aslan
OAOmur Aydin
Omur Aydin
AAAli Atan
Ali Atan

1 August 2005 in European Urology
Verified
Journal Article
Closed access
ATAltug Tuncel
Altug Tuncel
BUBurcin Uzun
Burcin Uzun
TETugrul Eruyar
Tugrul Eruyar
EKErdem Karabulut
Erdem Karabulut
SSSelda Seckin
Selda Seckin
AAAli Atan
Ali Atan

1 August 2022 in Journal of Endourology
Verified
Journal Article
Closed access
CACan Aykanat
Can Aykanat
MBMelih Balci
Melih Balci
CSCagdas Senel
Cagdas Senel
AOAli Yasin Ozercan
Ali Yasin Ozercan
SCSeref Coser
Seref Coser
ATAltug Tuncel
Altug Tuncel
Objective: To investigate the effect of the diameter of ureteral access sheath (UAS) used during retrograde intrarenal surgery (RIRS) on operative parameters, perioperative ureteral injury, and ureteral stricture development. Materials and Methods: The study was designed as a prospective randomized controlled trial and included 320 patients who underwent RIRS. The patients were divided into two groups according to the diameter of UAS (9.5F/11.5F [Group 1] and 12F/14F [Group 2]) placed during the operation. At the end of the operation, ureteral injury was checked visually using semirigid ureterorenoscopy and classified according to the ureter injury scale. In the postoperative first year, the control CT urography images were used to observe newly developing ureteral dilatation. Results: There was no statistical difference between the two groups in terms of patient and stone characteristics, operative time, postoperative stone-free rate, and postoperative infection development parameters. In Group 1, 30 (18.8%) of the patients had low-grade and 8 (5%) of the patients had high-grade ureteral injury, while in Group 2, 44 (27.5%) had low-grade and 19 (11.9%) had high-grade ureteral injury ( p = 0.013). In the postoperative period, ureteral stricture was found in 5 (1.6%) patients, of whom 4 (2.5%) were in Group 2 and 1 (0.6%) ( p = 0.371). Conclusion: The results of our study showed that the use of a 12F/14F UAS in patients who are not previously stented increases the risk of high-grade ureteral injuries; however, despite this increase there is no difference in ureteral stricture formation.

1 June 2008 in Urology
Verified
Journal Article
Closed access
ATAltug Tuncel
Altug Tuncel
UKUtku Kirilmaz
Utku Kirilmaz
VNVarol Nalcacioglu
Varol Nalcacioglu
YAYilmaz Aslan
Yilmaz Aslan
FPFazli Polat
Fazli Polat
AAAli Atan
Ali Atan

12 August 2014 in Renal Failure
Verified
Journal Article
Closed access
PDF file
MBMelih Balci
Melih Balci
ATAltug Tuncel
Altug Tuncel
OAOmur Aydin
Omur Aydin
YAYilmaz Aslan
Yilmaz Aslan
OGOzer Guzel
Ozer Guzel
AAAli Atan
Ali Atan
We evaluated the efficacy of tamsulosin and nifedipine in medical expulsive therapy (MET) in patients with distal ureteral stone. In addition, we tried to determine the predictive value of Hounsfield Unit (HU) of the stone in the success of MET. A total of 75 patients with a distal ureteral stone of 5–10 mm diameter were randomly divided into three groups. Group 1 (n = 25) received tamsulosin 0.4 mg/d; group 2 (n = 25) received nifedipine 10 mg/day p.o and group 3 (n = 25) received diclofenac sodium 50 mg p.o. when required. At the beginning of each treatment, the HU of the stone was also measured using a non-contrast computerized tomography in all the patients. The results were evaluated at week four. The mean age of the patients was 36.8 (range, 16–68) years. Stone expulsion was observed in 19 (76%) patients in group 1, 16 (64%) patients in group 2 and 9 (36%) patients in group 3 (pgroup1-3 = 0.004, pgroup2-3 = 0.048 and pgroup1-2 = 0.355). The mean expulsion time was 9, 9.1 and 10.3 d, respectively (pgroup1-3 < 0.001, pgroup2-3 < 0.001 and pgroup1-2 = 0.619). The mean diclofenac sodium dose per patient was 544, 602 and 1408 mg in groups 1, 2 and 3, respectively (pgroup1-3 < 0.001, pgroup2-3 < 0.001 and pgroup1-2 = 0.977). The mean HU of the stone in patients with and without a successful MET was 363 and 389, respectively (p = 0.462). Our results showed that MET with both nifedipine and tamsulosin provided a similar increase in the expulsion rate for distal ureteral stones. HU does not seem to be a predictive parameter for stone expulsion.